Beyond CRO: A Clinical Data Intelligence Company

Q2BI is evolving beyond a traditional CRO model to become a clinical data intelligence company.

At Q2BI, we pride ourselves on our commitment to innovation. As a pioneer in the integration of artificial intelligence into clinical research, we have seen firsthand how technology is reshaping the life sciences industry.

This change reflects our commitment to meeting the ever-changing needs of our sponsor organizations. We have always operated beyond the scope of a traditional CRO. Rather than simply delivering results according to the terms of a contract, we embed ourselves within the organizations we serve to gain a deep understanding of their goals, challenges and opportunities to drive meaningful impact.

This repositioning is not a departure from who we are, but rather a truer expression of the work we've always done. Our clients will continue to receive high-quality services and solutions, now enhanced by a greater focus on strategic integration with their organizations.

Our mission remains the same: confidently and carefully bringing promising therapies to patients sooner through hard work, innovative intelligence, and efficiency.

We aim to be the premier provider of AI-powered clinical trial services in the industry. Not for novelty, but because faster, more accurate decision-making drives better patient outcomes and advances the life sciences industry as a whole.